Healthpeak Properties, Inc. (DOC)
NYSE: DOC · Real-Time Price · USD
19.73
+0.09 (0.46%)
At close: May 22, 2026, 4:00 PM EDT
19.54
-0.19 (-0.96%)
After-hours: May 22, 2026, 7:32 PM EDT
Healthpeak Properties Stock Forecast
Stock Price Forecast
According to 20 analysts polled by S&P Global, Healthpeak Properties stock has a consensus rating of "Buy" and an average price target of $20.72. The average 1-year stock price forecast is 5.02% higher than the current stock price, while the lowest is $17 (-13.84%) and the highest is $29 (+46.98%).
Price Target: $20.72 (+5.02%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Healthpeak Properties stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Buy | 4 | 4 | 4 | 4 | 4 | 5 |
| Hold | 6 | 7 | 8 | 8 | 9 | 9 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 12 | 13 | 13 | 14 | 14 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Buy Maintains $18 → $20 | Buy | Maintains | $18 → $20 | +1.37% | May 22, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $20 → $21 | Buy | Maintains | $20 → $21 | +6.44% | May 14, 2026 |
| Baird | Baird | Buy Maintains $19 → $21 | Buy | Maintains | $19 → $21 | +6.44% | May 13, 2026 |
| Citigroup | Citigroup | Hold Maintains $18 → $20 | Hold | Maintains | $18 → $20 | +1.37% | May 12, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $21 → $18 | Buy | Maintains | $21 → $18 | -8.77% | Apr 28, 2026 |
Financial Forecast
Revenue This Year
2.88B
from 2.82B
Increased by 1.90%
Revenue Next Year
3.04B
from 2.88B
Increased by 5.56%
EPS This Year
0.19
from 0.10
Increased by 93.92%
EPS Next Year
0.24
from 0.19
Increased by 21.88%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 3.2B | 3.6B | ||||||
| Avg | 2.9B | 3.0B | ||||||
| Low | 2.6B | 2.7B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 13.3% | 24.9% | ||||||
| Avg | 1.9% | 5.6% | ||||||
| Low | -6.6% | -6.3% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 0.28 | 0.35 | ||||||
| Avg | 0.19 | 0.24 | ||||||
| Low | 0.15 | 0.15 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 183.5% | 78.7% | ||||||
| Avg | 93.9% | 21.9% | ||||||
| Low | 47.0% | -24.2% |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.